Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety

@article{Tamminga1997SertindoleIT,
  title={Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety},
  author={C. Tamminga and R. Mack and G. R. Granneman and C. Silber and K. B. Kashkin},
  journal={International Clinical Psychopharmacology},
  year={1997},
  volume={12},
  pages={S29–S36}
}
Evidence from clinical trials supports the claim that sertindole is a potent antipsychotic drug at a dose of 12–24 mg/day. Its action against positive symptoms is as potent as that of the traditional antipsychotic haloperidol. Its action against negative; symptoms is significantly different from that of placebo and quantitatively larger than that of haloperidol. Its most distinctive characteristic is a reduction in motor side effects over a whole range of comparable drug and comparator doses… Expand
38 Citations
Emerging role of sertindole in the management of schizophrenia
  • 13
  • PDF
Sertindole in schizophrenia: efficacy and safety issues
  • 9
Sertindole for the treatment of schizophrenia
  • 13
  • Highly Influenced
A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia
  • 49
Efficacy and Safety of Sertindole in Schizophrenia: A Clinical Review
  • 5
Sertindole in the long-term treatment of schizophrenia
  • 5
...
1
2
3
4
...